PHILADELPHIA, PA / ACCESSWIRE / April 2, 2014 / Olfactory Biosciences Corp (OLFC) is pleased to launch today a new special improved and timely product, NOXO Sensory Balm™. http://noxoinfo.com/sensory
The new NOXO Sensory Balm(tm) is being launched at a time of heightened awareness of the alarming, increasing incidence of autism. At the same time, a growing body of research into sensory perception reveals quantifiable differences in brain structure, confirming a biological basis for sensory processing disorder (SPD) that sets it apart from neurodevelopmental disorders such as ADHD and autism.
Increasingly, clinicians are struggling to differentiate between these conditions to make an accurate diagnosis and perhaps more important, to provide the most appropriate interventions. Regardless of whether a child, teen or adult has autism, SPD or another conditions, both the person, family members, teachers and other caregivers need help.
Sensory processing challenges can include out-of-proportion reactions to everyday sensations that simply do not bother others. These issues can include hypersensitivity to smell, touch, noise, visuals, movement and more.
This hypersensitivity, typically seen in its most severe form in people with autism, can make everyday life very uncomfortable or even painful.
New NOXO Sensory Balm(tm), applied topically under the nose of a person with sensory issues, may provide relief from environmental odors and sensory processing issues that have the potential to trigger maladaptive coping responses.
The NOXO molecules transport their “messages” directly to the brain’s emotional center–the limbic system–which can change behavior by reducing the intensity or the way the brain receives sensory messages.
NOXO Sensory Balm(tm) was invented by Olfactory Biosciences Corp using both the company’s proprietary science and that of the NOBEL Prize in Medicine Winners of 2004 Richard Axel and Linda Buck. The company has been successful in targeting olfactory receptors with the company’s proprietary balm’s scents resulting in the desired modifications.
Ingredients: A special proprietary formulation of Phytonutrients and Phytochemicals taken from plants, flowers, roots and seeds. All ingredients are in a high quality White Petrolatum that complies with White Petrolatum USP requirements and FDA requirements ( 21 CFR 172.880) The specific chemical identities of the ingredients in this mixture are considered by us to be trade secrets and are withheld in accordance with the provisions of the 1910.1200 of the Code of Federal Regulations **Our products are free of bee pollen, lactose, peanuts, tree nuts, shellfish, gelatin and are all organic ingredients, and free of allergens (such as milk, wheat, gluten)**. Further Information and purchasing can be found at http://noxoinfo.com/sensory. For more information about sensory processing issues check out these books online, in stores, or in libraries – LINDSEY BIEL, OTR/L Author, Sensory Processing Challenges: Effective Clinical Work with Kids & Teens Co-author, Raising a Sensory Smart Child, foreword by Temple Grandin.
About Olfactory Biosciences Corp.
Olfactory Biosciences Corp.’s NOXO division is focused to develop a variety of products targeting Olfactory Receptors in the nose for the desired effect. These alternative medicine wellness products can modify behavior or provide relief to common behavior challenges such as anxiety or weight control, as examples.
FORWARD-LOOKING STATEMENTS “Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995: Statements by the Company, statements regarding the NOXO product line, optimism related to the business, expanding ales and other statements in this press release are forward-looking statements within the meaning of the Securities Litigation Reform Act of 1995. Such statements are based on current expectations, estimates and projections about the Company’s business. Words such as expects, anticipates, intends, plans, believes, sees, estimates and variations of such words and similar expressions are intended to identify such forward-looking statements. These statements are not guarantees of future performance and involve certain risks and uncertainties that are difficult to predict. Actual results could vary materially from the description contained herein due to many factors including continued market acceptance of the Company’s products or the need to raise additional capital. In addition, actual results could vary materially based on changes or slower growth in the indoor garden market; the potential inability to realize expected benefits and synergies; domestic and international business and economic conditions; changes in customer demand or ordering patterns; changes in the competitive environment including pricing pressures or technological changes; technological advances; shortages of manufacturing capacity; future production variables impacting excess inventory and other risk factors listed from time to time in the Company’s Securities and Exchange Commission (SEC) filings under “risk factors” and elsewhere. The forward-looking statements contained in this press release speak only as of the date on which they are made, and the Company does not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this press release.
Richard Stevenson, President
Olfactory Biosciences Corp.
333 E. Lancaster Ave. Suite
317 Wynnewood, PA 19096, USA
Source: Olfactory Biosciences Corp.